News

Pictured: T cells
Cancer Immunotherapy Named Science Magazine “Breakthrough of the Year”

Memorial Sloan Kettering researchers have played a major role in cancer immunotherapy research, named “Breakthrough of the Year” by Science magazine.

Monday, December 23, 2013
Pictured: Alexander Rudensky
At Work: Immunologist Alexander Rudensky

Alexander Rudensky’s research focuses on the role of a subset of white blood cells called regulatory T cells, which are believed to suppress the immune system’s ability to fight tumors.

Monday, December 16, 2013
Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell
Molecular Studies Explain Effectiveness of Longtime Treatment for Prostate Cancer

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.

Thursday, December 12, 2013
Pictured: Ross Levine
New Diagnostic Test for Blood Cancers Will Help Doctors Tailor Treatments

A new diagnostic test co-developed by Memorial Sloan Kettering identifies hundreds of genetic alterations in blood cancers, which will guide physicians in treatment decisions.

Monday, December 9, 2013
Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
New Biotech Startup Will Pit the Immune System Against Cancer

Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines.

Friday, December 6, 2013
Pictured: Casper zebrafish
Transparent Fish Reveal Secrets of Tumor Spread

Physician and cell biologist Richard White has generated a transparent and stripeless strain of zebrafish to study how tumors develop the capacity to metastasize to new organs.

Tuesday, December 3, 2013
Pictured: Joan Massagué
Cancer Biologist Joan Massagué Named Director of the Sloan Kettering Institute

Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.

Monday, November 25, 2013
Study Reveals Genetic Causes for Thyroid Cancer Increase after Chernobyl

The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops.

Wednesday, November 13, 2013
Pictured: Sarat Chandarlapaty
Researchers Identify Mutations that Cause Some Breast Cancers to Resist Treatment

Memorial Sloan Kettering researchers have found genetic mutations that cause some breast cancers to develop resistance to hormone therapy.

Friday, November 8, 2013
Pictured: Stephen Long & Alexandria Miller
At Work: Structural Biologist Stephen Long

Stephen Long works to understand how proteins work by determining what they look like in three dimensions.

Thursday, November 7, 2013